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Abstract
Substantial evidence supports a role for myocyte enhancer factor 2 (MEF2)-mediated transcription in neuronal survival,
differentiation and synaptic function. In developing neurons, it has been shown that MEF2-dependent transcription is
regulated by neurotrophins. Despite these observations, little is known about the cellular mechanisms by which
neurotrophins activate MEF2 transcriptional activity. In this study, we examined the role of salt-inducible kinase 1 (SIK1),
a member of the AMP-activated protein kinase (AMPK) family, in the regulation of MEF2-mediated transcription by the
neurotrophin brain-derived neurotrophic factor (BDNF). We show that BDNF increases the expression of SIK1 in primary
cultures of rat cortical neurons through the extracellular signal-regulated kinase 1/2 (ERK1/2)-signaling pathway. In
addition to inducing SIK1 expression, BDNF triggers the phosphorylation of SIK1 at Thr182 and its translocation from
the cytoplasm to the nucleus of cortical neurons. The effects of BDNF on the expression, phosphorylation and,
translocation of SIK1 are followed by the phosphorylation and nuclear export of histone deacetylase 5 (HDAC5).
Blockade of SIK activity with a low concentration of staurosporine abolished BDNF-induced phosphorylation and
nuclear export of HDAC5 in cortical neurons. Importantly, stimulation of HDAC5 phosphorylation and nuclear export by
BDNF is accompanied by the activation of MEF2-mediated transcription, an effect that is suppressed by staurosporine.
Consistent with these data, BDNF induces the expression of the MEF2 target genes Arc and Nur77, in a staurosporine-
sensitive manner. In further support of the role of SIK1 in the regulation of MEF2-dependent transcription by BDNF, we
found that expression of wild-type SIK1 or S577A SIK1, a mutated form of SIK1 which is retained in the nucleus of
transfected cells, is sufficient to enhance MEF2 transcriptional activity in cortical neurons. Together, these data identify
a previously unrecognized mechanism by which SIK1 mediates the activation of MEF2-dependent transcription by
BDNF.
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Introduction
Salt-inducible kinase 1 (SIK1) is a member of the AMP-
activated protein kinase (AMPK) family of Ser/Thr kinases
originally identified from the adrenal glands of high salt diet-
treated rats [1]. In the central nervous system, SIK1 is expressed in
striatal, cortical, hippocampal and hypothalamic neurons
[2,3,4,5]. The expression of SIK1 was found to be regulated by
neuronal activity in vitro and in vivo [3,4,5]. In addition to SIK1,
the SIK family includes two other members, i.e. SIK2 and SIK3.
SIK2 is predominantly expressed in adipose tissue and is involved
in neuronal survival [6,7] and in the suppression of melanogenesis
in melanocytes [8,9]. The ubiquitously expressed SIK3 isoform
induces chondrocyte differentiation [10] and regulates glucose and
lipid metabolism [11].
SIK1 was initially shown to act as a repressor of cAMP-
dependent transcription of steroidogenic enzymes [12], and was
later found to repress cAMP response element-binding protein
(CREB) transcriptional activity by phosphorylating CREB-regu-
lated transcription coactivators (CRTCs) [13,14]. Thus, phos-
phorylation of CRTCs by SIK1 triggers nuclear export and
cytoplasmic sequestration of CRTCs, thereby preventing activa-
tion of CREB-mediated transcription [14,15].
More recently, SIK1 was shown to promote the phosphoryla-
tion of class II histone deacetylases (HDACs) [16,17] that repress
transcription by associating with a variety of transcription factors
and corepressors [18]. In particular, SIK1 was found to
phosphorylate and inactivate class II HDACs in skeletal muscle,
thus enhancing myocyte enhancer factor 2 (MEF2) transcriptional
activity and expression of MEF2 target genes [17]. Similarly, KIN-
29, the homolog of SIK in C. elegans, was shown to phosphorylate
and inactivate class II HDACs in chemosensory neurons, thereby
upregulating chemoreceptor gene expression via the C. elegans
MEF2 ortholog MEF-2 [16]. Together, these studies provide
evidence that phosphorylation of class II HDACs by SIK1 leads to
the activation of MEF2-dependent transcription in different cell
types.
There is compelling evidence supporting a role for MEF2
transcription factors in neuronal survival, differentiation and
synapse development [19,20]. For instance, inhibition of MEF2
activity causes apoptotic cell death in cortical neurons, suggesting
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that MEF2-dependent transcription is necessary for neuronal
survival [21]. In addition, activation of MEF2-dependent
transcription was found to regulate synapse elimination in the
hippocampus and cerebellum [22,23,24].
In developing neurons, MEF2-mediated transcription is regu-
lated by a number of stimuli such as calcium influx resulting from
neuronal activity [22,23] and neurotrophin-mediated signaling
[22,23,25,26,27,28]. In particular, the neurotrophin brain-derived
neurotrophic factor (BDNF) was shown to activate MEF2-
mediated transcription in cerebellar granule and cortical neurons
[25,26,27,29].
Together, these observations led us to examine the role of SIK1
in the regulation of MEF2-dependent transcription by BDNF. In
the present study, we show that BDNF induces the expression,
phosphorylation and, translocation of SIK1 in cortical neurons.
These effects of BDNF are followed by the phosphorylation and
nuclear export of HDAC5, leading to the activation of MEF2-
mediated transcription.
Materials and Methods
Cortical Neuron Culture
Primary cultures of cortical neurons were prepared from 18-
day-old Sprague Dawley rat embryos, as previously described
[30]. Dissociated cells were plated at a density of 60,000 cells/cm2
on poly-D-lysine (Sigma-Aldrich) coated dishes or glass coverslips,
and were cultured in Neurobasal medium (Invitrogen) supple-
mented with B-27 (Invitrogen), 0.5 mM glutamine (Sigma-Aldrich)
and 2 mM glutamate (Sigma-Aldrich). Cortical neurons were
maintained for 4 days at 37uC in a humidified atmosphere
consisting of 95% air and 5% CO2.
Ethics Statement
All experiments complied with the Swiss federal act on animal
protection and the Swiss animal protection ordinance, and were
approved by the veterinary office of Canton de Vaud (Lausanne,
Switzerland, permit Number 684.9).
Cell Stimulation
After 4 days in vitro, cortical neurons were treated with 10 ng/
ml BDNF (Alomone Labs). When indicated, neurons were also
exposed to 50 mM U0126 (Calbiochem), 10 mM LY294002
(Calbiochem), 10 mM KN-62 (Tocris Bioscience), or 10 nM
staurosporine (LC Laboratories) 30 min before stimulation with
BDNF. U0126, LY294002, KN-62 and staurosporine were
solubilized in dimethyl sulfoxide (DMSO), and the same volume
of DMSO (final concentration 0.1%) was added into the medium
of non-treated cultures as vehicle.
Lipofection
For immunocytochemistry experiments, cortical neurons grown
on glass coverslips were transfected after 3 days in vitro with
pCAG-GFP (Addgene plasmid # 11150) [31], pCDNA3.1-
HDAC5-FLAG (Addgene plasmid # 13822) [32], pGFPC-rat
SIK1 [13], or pGFPC-rat S577A SIK1 [13] using Lipofectamine
2000 reagent (Invitrogen), according to the manufacturer’s
instructions. pGFPC-rat SIK1 and pGFPC-rat S577A SIK1 were
kindly provided by Dr H. Takemori. For MEF2-luciferase assay
experiments, cortical neurons were transfected 5 h after plating
using Lipofectamine 2000 reagent with pMEF2FLuc [33], pUB6-
lacZ [34], and when indicated with pCAG-GFP, pGFPC-rat
SIK1, or pGFPC-rat S577A SIK1.
Nucleofection
Nucleofection of pGFPC-rat SIK1 [13] was performed on
56106 dissociated cortical neurons using the rat neuron
nucleofector kit and the nucleofector device (Amaxa Biosystems,
Lonza, Switzerland), according to the manufacturer’s instructions.
Transfected cells were plated at a density of 100,000 cells/cm2.
Real-time Quantitative PCR Analysis
Total RNA was isolated from 4 days in vitro cortical neurons
using RNeasy Plus Mini kit (Qiagen), according to the manufac-
turer’s instructions. 200 ng of total RNA was used for reverse
transcription into first-strand cDNA with TaqMan reverse
transcription reagents (Applied Biosystems). The resulting cDNA
was then amplified by real-time quantitative PCR using Power
SYBR Green PCR Master Mix (Applied Biosystems) and a 7500
Real-Time PCR System (Applied Biosystems). The following
primer pairs were used for specific mRNA amplification: Arc,
forward 59-GAA CGA CAC CAG GTC TCA AG-39, reverse 59-
TTT CTC TGC CTT GAA AGT GTC-39; Gapdh, forward 59-
ATG TAT CCG TTG TGG ATC TGA CAT-39, reverse 59-
ACC TGC TTC ACC ACC TTC TTG A-39; Nur77, forward 59-
CGG AGA TGC CCT GTA TCC-39, reverse 59-ATG GTG
GGC TTG CTG AAC-39; Sik1, forward 59-AGC TTT ACC
AGG TTA TGG AG-39, reverse 59-AGT CAG ATA ATC GAA
CAT TTC TC-39. The analysis of relative mRNA levels was
performed using a delta-CT (DDCt) relative quantification model
[35] with gapdh as a reference gene. Each value is expressed as
fold change relative to the mRNA level of the control value.
Western Blot Analysis
Western blot analysis was performed, as previously described
[30], with rabbit anti-SIK1 (1:5000) and rabbit anti-phospho-
Thr182 SIK1 (1:1000) antibodies generously provided by Dr H.
Takemori (National Institute of Biomedical Innovation, Osaka,
Japan), rabbit anti-phospho-Ser259 HDAC5 antibody (1:1000;
Abcam) and mouse anti-b-tubulin antibody (1:1000, Sigma-
Aldrich). ECL horseradish peroxidase-conjugated anti-rabbit and
anti-mouse antibodies (1:10,000; Amersham Biosciences) were
used as secondary antibodies. The total densitometric value of
each band was quantified with ImageJ software (National Institute
of Health), normalized to the corresponding b-tubulin level, and
expressed as fold change relative to the control value.
Immunocytochemistry
After 4 days in vitro, cortical neurons grown on glass coverslips
were processed for immunocytochemistry, as previously described
[36]. Neurons were immunostained with mouse anti-FLAG M2
(1:1000, Sigma Aldrich), mouse anti-MAP2 (1:1000, Sigma
Aldrich), and rabbit anti-GFP (1:500, Invitrogen) antibodies.
Alexa Fluor 546 goat anti-mouse and Alexa Fluor 488 goat anti-
rabbit (Invitrogen) were used as secondary antibodies. Cells were
then counterstained with DAPI (Invitrogen), and glass coverslips
were mounted with Prolong Gold antifade reagent (Invitrogen) on
microscope slides. Images were analyzed with an Axioplan 2
fluorescence microscope (Zeiss). To characterize the subcellular
localizations of HDAC5-FLAG and SIK1-GFP, FLAG and GFP
immunofluorescence intensities were quantified with ImageJ
software in the cytoplasmic and nuclear compartments of
transfected neurons. The cytoplasmic and nuclear compartments
of neurons co-transfected with pCAG-GFP and HDAC5-FLAG
were delineated using GFP immunostaining and DAPI counter-
staining, respectively and with MAP2 immunostaining and DAPI
counterstaining for neurons transfected with SIK1-GFP. Data are
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shown as the ratio of HDAC5-FLAG or SIK1-GFP immunoflu-
orescence intensity in the nucleus to the cytoplasm of transfected
neurons.
MEF2-luciferase Assay
Cortical neurons at 4 days in vitro were lysed in luciferase cell
culture lysis reagent (Promega) and processed for luciferase activity
with the luciferase assay system (Promega) and a Turner-Designs
TD-20/20 luminometer (DLReady), according to the manufac-
turer’s instructions. Lysed cells were also processed for b-
galactosidase activity using Galacto-Light chemiluminescent
reporter gene assay (Applied Biosystems). Data are expressed as
the ratio of luciferase activity to b-galactosidase activity, and are
shown as fold changes relative to the control value.
Statistical Analysis
Data are shown as the mean 6 SEM of n values, from at least
three independent experiments. Statistical significance was ana-
lyzed with one-way ANOVA followed by Bonferonni’s or
Dunnett’s post hoc test using PASW-SPSS 18.0 software (IBM).
The statistical significance is shown as *p,0.05, **p,0.01,
***p,0.001, and NS p.0.05.
Results
As a first step towards assessing the role of SIK1 in the
activation of MEF2-dependent transcription by BDNF, we
examined the regulation of SIK1 expression by BDNF. We found
that treatment of cortical neurons with BDNF increases SIK1
mRNA levels (Fig. 1A) and protein expression (Fig. 1C–D). The
increase in SIK1 mRNA levels induced by BDNF was completely
abolished by treatment with the MEK1/2 inhibitor U0126,
whereas inhibition of the PI3K signaling pathway by LY294002
did not affect BDNF-induced increases in SIK1 mRNA levels
(Fig. 1B). These data indicate that BDNF induces SIK1 expression
via a MEK1/2-dependent, PI3K-independent mechanism. Be-
cause there is evidence that SIK1 is activated through phosphor-
ylation at Thr182 [37], we examined whether BDNF regulates
SIK1 Thr182 phosphorylation. Our data revealed that treatment
of cortical neurons with BDNF induced a transient phosphoryla-
tion of SIK1 at Thr182 (Fig. 2A–B). In addition, phosphorylation
of SIK1 by BDNF was accompanied by the translocation of SIK1
from the cytoplasm to the nucleus of cortical neurons (Fig. 2C–D).
Together, these data show that BDNF induces the expression,
phosphorylation and, translocation of SIK1 in cortical neurons.
Because there is evidence that SIK1 triggers HDAC5
phosphorylation in skeletal muscle [17], we next examined
whether induction of SIK1 expression, phosphorylation and,
nuclear translocation by BDNF was accompanied by changes in
the phosphorylation of HDAC5 at Ser259. Our data revealed that
exposure of cortical neurons to BDNF increases phospho-Ser259
HDAC5 expression (Fig. 3A). This effect was suppressed by
addition of a low concentration (10 nM) of staurosporine (Fig. 3B),
a Ser/Thr kinase inhibitor that blocks SIK activity [15]. As
phosphorylation of HDAC5 is known to trigger its nuclear export,
we examined whether HDAC5 phosphorylation induced by
BDNF leads to its subcellular relocalization in cortical neurons.
Using an HDAC5-FLAG protein to monitor changes in cellular
localization, we found that HDAC5-FLAG was targeted predom-
inantly to the nucleus of cortical neurons in naive cultures,
whereas treatment with BDNF induced the redistribution of
HDAC5-FLAG to the cytoplasm of transfected neurons (Fig. 4A–
B). Consistent with the important role of SIK1 in the nuclear-to-
cytoplasmic shuttling of class II HDACs [17], blockade of SIK
activity by staurosporine resulted in the strong nuclear accumu-
lation of HDAC5-FLAG in cortical neurons exposed or not to
BDNF (Fig. 4A–B). These data provide evidence that activation of
SIK1 by BDNF induces the phosphorylation and nuclear export of
HDAC5 in cortical neurons.
Class II HDACs interact directly with MEF2 transcription
factors to repress gene expression in skeletal muscle [38].
However, phosphorylation and subsequent nuclear export of class
II HDACs leads to the derepression of MEF2-dependent
transcription [39]. These observations led us to investigate
whether the effect of BDNF on HDAC5 phosphorylation and
nuclear export was accompanied by activation of MEF2-mediated
transcription. Using a MEF2-luciferase reporter assay to monitor
MEF2 activity, we found that treatment of cortical neurons with
BDNF significantly increased MEF2 transcriptional activity
(Fig. 5A), whereas BDNF-induced MEF2 transcriptional activity
was completely suppressed by staurosporine (Fig. 5B). Because it
has been shown that activation of MEF2 is also mediated by
CaMKII [40,41], we examined whether inhibition of CaMKII by
KN-62 alters the activation of MEF2 by BDNF. We found that
KN-62 did not affect BDNF-induced MEF2 activity (Fig. 5B),
ruling out the involvement of CaMKII in the activation of MEF2-
dependent transcription by BDNF. These data provide evidence
that the induction of SIK1 expression, phosphorylation and,
nuclear translocation by BDNF and the consequent stimulation of
HDAC5 phosphorylation and nuclear export leads to the
induction of MEF2 transcriptional activity.
To further characterize the role of SIK1 in the regulation of
MEF2-mediated transcription by BDNF, we examined the
regulation of the expression of the prototypical MEF2 target
genes Arc and Nur77 [22,42] by BDNF and staurosporine.
Consistent with the regulation of MEF2 activity, our data revealed
that BDNF induces the upregulation of Arc and Nur77, an effect
abolished after inhibition of SIK1 activity by staurosporine
(Fig. 5C–D).
To further support the role of SIK1 in the regulation of MEF2-
dependent transcription by BDNF, we examined MEF2 activity in
transfected neurons expressing wild-type SIK1 or a mutated form
of SIK1, S577A SIK1, which is retained in the nucleus of
transfected cells [13]. These data revealed that expression of wild-
type SIK1 and S577A SIK1 are sufficient to stimulate MEF2
transcriptional activity (Fig. 5E). However, treatment of cortical
neurons with staurosporine abolished the effects of expressing
wild-type SIK1 and S577A SIK1 on MEF2 activity (Fig. 5E).
Interestingly, expression of S577A SIK1 has a greater effect on
MEF2 transcriptional activity than expression of wild-type SIK1
(Fig. 5E), which is consistent with the increased nuclear
localization of the mutant compared to the wild-type form of
SIK1 (Fig. 5F). Together, these data unveil the critical role of
SIK1 in the regulation of MEF2 transcriptional activity by BDNF.
Discussion
Data from this study show that BDNF stimulates MEF2
transcriptional activity through a novel molecular mechanism.
Thus, by inducing the expression, phosphorylation, and nuclear
translocation of SIK1, BDNF phosphorylates HDAC5 and
triggers its nuclear export resulting in enhanced MEF2-dependent
transcription in cortical neurons.
Previous studies in different cell types have shown that the
expression of SIK1 is upregulated by the cAMP/PKA signaling
pathway. For instance, forskolin induces SIK1 expression in
primary myocytes, C2C12 myoblasts and hypothalamic neurons
[4,17]. Other studies have reported that the b-adrenergic receptor
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Figure 1. BDNF enhances the expression of SIK1 through the MAPK signaling pathway. A, SIK1 mRNA expression was analyzed by real-
time quantitative PCR in cortical neurons treated with BDNF for the indicated time points. Results represent the mean 6 SEM of 3–6 independent
experiments. B, The expression of SIK1 mRNA was analyzed by real-time quantitative PCR in neurons treated with BDNF for 1 h in the presence of the
MEK1/2 inhibitor U0216, the PI3K inhibitor LY294002, or the vehicle (Veh). Results are the mean 6 SEM of 3 independent experiments. ***p,0.001;
NS, not significantly different. C, Western blot analysis of SIK1 protein expression in neurons treated with BDNF. D, SIK1 protein levels are expressed
as fold changes relative to the control (Ctrl) value, and are the mean 6 SEM of 5–8 independent experiments.
doi:10.1371/journal.pone.0054545.g001
Figure 2. BDNF induces phosphorylation and nuclear translocation of SIK1. A, Western blot analysis of phospho-Thr182 SIK1 (p-Thr182
SIK1) expression in cortical neurons transfected with SIK1-GFP and treated with BDNF. B, p-Thr182 SIK1 protein levels are expressed as fold changes
relative to the control (Ctrl) value, and are the mean 6 SEM of 3 independent experiments. C, Cortical neurons were transfected with SIK1-GFP and
treated with BDNF. After treatment, cortical neurons were immunostained for GFP and MAP2, followed by DAPI counterstaining. Scale bar = 10 mm.
D, Quantitative analysis of the nuclear/cytoplasmic ratio (N/C) of SIK1-GFP immunofluorescence in Ctrl and BDNF-treated cortical neurons.
Cytoplasmic and nuclear compartments were determined with MAP2 immunostaining and DAPI counterstaining, respectively. Results are the mean
6 SEM of at least 54 neurons from 4 independent experiments. ***p,0.001 and NS, not significantly different, compared to Ctrl by one-way ANOVA
followed by Dunnett’s post hoc test.
doi:10.1371/journal.pone.0054545.g002
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agonist isoproterenol upregulates SIK1 expression in skeletal
muscle and pinealocytes [17,43]. In developing cortical neurons,
evidence indicates that membrane depolarization by KCl induces
SIK1 expression, an effect that is abolished by the L-type voltage-
gated calcium channel blocker nifedipine [3]. In the present study
we show, for the first time, that the expression of SIK1 is
upregulated in developing neurons by the neurotrophic factor
BDNF (Fig. 1).
In addition to inducing SIK1 expression, BDNF triggers the
phosphorylation and nuclear translocation of SIK1 (Fig. 2).
Interestingly, it has been shown that phosphorylation of SIK1 at
Thr182 is mediated by the liver kinase B1 (LKB1) [37,44],
Figure 3. Stimulation of HDAC5 phosphorylation by BDNF is mediated by a staurosporine-sensitive mechanism. A, Left panel,
western blot analysis of phospho-Ser259 HDAC5 (p-HDAC5) expression in cortical neurons treated with BDNF. Right panel, p-HDAC5 protein levels
are presented as fold changes relative to the control (Ctrl) value and are the mean 6 SEM of 4–6 independent experiments. B, Left panel, western
blot analysis of p-HDAC5 expression in neurons treated with BDNF for 3 h in the presence of staurosporine (STS) or vehicle (Veh). Right panel,
quantitative analysis of p-HDAC5 protein levels. Data are the mean 6 SEM of 4–5 independent experiments. ***p,0.001.
doi:10.1371/journal.pone.0054545.g003
Figure 4. Effects of BDNF and staurosporine on the subcellular localization of HDAC5. A, Cortical neurons expressing GFP and HDAC5-
FLAG were treated with BDNF for 3 h in the presence of staurosporine (STS) or vehicle (Veh). After treatment, cells were immunostained for GFP and
FLAG, followed by DAPI counterstaining. Scale bar = 10 mm. B, Quantitative analysis of the nuclear/cytoplasmic ratio (N/C) of HDAC5-FLAG
immunofluorescence in cortical neurons treated with BDNF and STS. Nuclear and cytoplasmic compartments were determined with DAPI
counterstaining and GFP immunostaining, respectively. Results represent the mean 6 SEM of at least 55 neurons from 3 independent experiments.
***p,0.001.
doi:10.1371/journal.pone.0054545.g004
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suggesting that BDNF increases SIK1 phosphorylation at Thr182
by activating LKB1. Consistent with this hypothesis, BDNF has
been shown to stimulate LKB1 activity in cortical and hippocam-
pal neurons [45,46]. In addition, BDNF-induced SIK1 phosphor-
ylation at Thr182 is associated with its nuclear translocation
(Fig. 2C–D). In line with these findings, it is interesting to note that
Figure 5. Role of SIK1 in the induction of MEF2-dependent transcription by BDNF. A, Cortical neurons transfected with pMEF2FLuc and
pUB6-lacZ were treated with BDNF for the indicated time points. Results represent MEF2-luciferase activity normalized to b-galactosidase activity, and
are expressed as fold changes relative to the control (Ctrl) value. Data are the mean 6 SEM of at least 6 determinations from 3–5 independent
experiments. ***p,0.001, **p,0.01 compared with the control (Ctrl) value. B, Cortical neurons transfected with pMEF2FLuc and pUB6-lacZ were
treated with BDNF for 6 h in the presence of staurosporine (STS), KN-62 or vehicle (Veh). MEF2 luciferase activity is expressed as fold changes relative
to MEF2 activity in neurons treated with Veh. Data are the mean 6 SEM of 7–10 determinations from 3–5 independent experiments. C–D, The
expression of Arc (C) and Nur77 (D) mRNAs was analyzed by real-time quantitative PCR after treatment of cortical neurons with BDNF for 1 h in the
presence of STS or Veh. Results are the mean6 SEM of 4 independent experiments. E, Cortical neurons were transfected with pMEF2FLuc and pUB6-
lacZ along with plasmids encoding GFP, SIK1-GFP, or S577A SIK1-GFP, and were then exposed to STS or Veh. for 6 h. Data are expressed as in (A) and
(B), and are the mean 6 SEM of 10–13 determinations from 4 independent experiments. ***p,0.001, **p,0.01, *p,0.05. F, Cortical neurons
transfected with SIK1-GFP and S577A SIK1-GFP were immunostained for GFP followed by DAPI counterstaining. Scale bar = 10 mm.
doi:10.1371/journal.pone.0054545.g005
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intraperitoneal injection of cocaine induces both phosphorylation
of SIK1 at Thr182 and translocation of SIK1 from the cytoplasm
to the nucleus of rat striatal neurons [2].
Importantly, our data show that induction of SIK1 expression,
phosphorylation and, nuclear translocation by BDNF is followed
by the increased phosphorylation and nuclear export of HDAC5
(Fig. 3–4), as well as by the activation of MEF2 transcriptional
activity (Fig. 5A) and MEF2-dependent gene expression (Fig. 5C–
D). Interestingly, previous studies have shown that the SIK1-
HDAC5-MEF2 pathway is also activated in skeletal and cardiac
muscle cells. Thus, in skeletal myocytes and C2C12 myoblasts,
induction of SIK1 expression by forskolin or isoproterenol
increases the phosphorylation and nuclear export of HDAC5,
thereby enhancing MEF2-dependent transcription [17]. In line
with these data, overexpression of SIK1 was found to induce
nuclear export of HDAC5 and activation of MEF2C in C2C12
myoblasts [47]. In addition, recent evidence indicates that
induction of SIK1 expression and activity by increases in
intracellular sodium concentration in a cardiac myocyte cell line
activates MEF2 through HDAC5 phosphorylation [48]. Together,
these observations provide evidence that regulation of MEF2
activity by the induction of SIK1 expression and phosphorylation
of HDAC5 is not limited to neuronal cells but extend to other cell
types such as skeletal and cardiac muscle cells.
The transcriptional activity of MEF2 is regulated by direct
phosphorylation and by indirect mechanisms [19,39,49]. In
particular, activation of p38 MAPK and ERK5 was shown to
increase MEF2 transcriptional activity through the phosphoryla-
tion of MEF2 transactivation domain [19,39,49]. In addition, it is
well established that phosphorylation of class II HDACs leads to
their nuclear-to-cytoplasmic shuttling and to the subsequent
derepression of MEF2 [39,49]. Although most of these studies
are related to skeletal muscle differentiation or cardiac growth
[18], there is also evidence that KCl-induced depolarization of
cerebellar granule and hippocampal neurons induces nuclear
export of HDAC5, resulting in increased MEF2 activity [40,50].
In this context, our study provides the first evidence of the
stimulation of MEF2 activity by a neurotrophic factor through the
increased phosphorylation and nuclear export of HDAC5 (Fig. 3–
4, 5A).
Interestingly, BDNF was previously shown to stimulate MEF2-
dependent transcription through the activation of ERK5 in
cortical and cerebellar granule neurons [25,26,27]. More recently,
BDNF was found to activate MEF2C-mediated transcription in
cortical neurons through ERK1/2-p90 ribosomal S6 kinase 2
(RSK2) signaling pathway [29]. These findings, together with our
data, indicate that activation of ERK1/2 by BDNF can stimulate
MEF2-dependent transcription by inducing SIK1 expression
(Fig. 1) followed by the nuclear export of HDAC5 (Fig. 4) and
by the direct phosphorylation of MEF2C by RSK2 [29]. These
results support the view that SIK1-mediated inactivation of
HDAC5 may act in cooperation with RSK2-dependent phos-
phorylation of MEF2 to activate MEF2 transcriptional activity in
response to BDNF.
In addition to regulating MEF2-dependent transcription,
previous studies have revealed an important role for SIK1 in
controlling CREB-mediated transcription. Thus, SIK1 inhibits
CREB transcriptional activity by phosphorylating CRTCs,
triggering their nuclear export and cytoplasmic sequestration
[13,15,51]. These data provide evidence that MEF2- and CREB-
mediated transcription are regulated in opposite directions by
SIK1 through the phosphorylation of HDAC5 and CRTCs,
respectively.
Together, our data identify a novel signaling pathway by which
BDNF stimulates MEF2 activity. Thus, by inducing the expres-
sion, phosphorylation and, nuclear translocation of SIK1, BDNF
increases HDAC5 phosphorylation and nuclear export, resulting
in derepression of MEF2 activity. Because BDNF controls many
aspects of neuronal development and synaptic plasticity, charac-
terization of the role of SIK1-mediated activation of MEF2 in the
effects of BDNF on neuronal survival, differentiation and synaptic
transmission should improve our understanding of the mecha-
nisms by which BDNF regulates neuronal development and
function.
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